The Graduate Program in Medicine and Human Health (PPgMSH) at Escola Bahiana de Medicina e Saúde Pública completed 20 years with a special online program, held on September 18, through the institution's official channel on YouTube. To celebrate the breadth of research and science developed over two decades, the International Webinar "A Critical View of Evidence-Based Medicine" was held, with a lecturer by the adjunct professor and director of the Center for Evidence-Based Medicine at Bahiana, Dr. Luís Claudio Correia, and international guests Dr. John Mandrola (USA) and Dr. Robert Kaplan (USA).
The opening virtual table was attended by the dean of Bahiana, Dr. Maria Luisa Carvalho Soliani, from the Dean of Research, Innovation and Postgraduate Studies Stricto Sensu, Dr. Atson Fernandes, from the Coordinator of the Postgraduate Program in Medicine and Human Health, Dr. Ana Marice Teixeira Ladeia, from coordinator of the Neurosciences Center of the Bahiana and former coordinator of PPgMSH, Dr. Bernardo Galvão, and guest Dr. Luiz Felipe Ribeiro Pinto, coordinator of Medicine 1 at CAPES.
In her explanation, Dr. Ana Marice presented a history of the program that began in 2000 as a Post-Graduate Course in Internal Medicine, then exclusively aimed at female doctors and physicians. In 2005, under the coordination of Dr. Bernardo Galvão, it was renamed the Graduate Program in Medicine and Human Health, becoming also open to other health professionals and related areas.
In 2016, the institutional doctoral program for the qualification of professors at the Bahiana and, in 2018, the initiative was expanded to the institutional master's program, also aimed at in-house teachers. Currently, due to the COVID-19 pandemic, PPgMSH underwent a pedagogical structure that enabled the full continuity of its online activities.
"Science, technology and innovation. This acronym is the driving force for social development and for the country's wealth. This is a very important moment for us because 20 years of a program that proposes to promote science is a trademark of a institution whose purpose is the regional and national development", highlighted Dr. Atson Fernandes.
The report by Dr. Maria Luisa Carvalho Soliani led the broadcast audience to the beginning of the entire process of creating the PPgMSH, when the then general coordinator of the Foundation Bahiana for Science Development, Dr. Humberto de Castro Lima, invited Dr. Bernardo Galvão to develop the research at the institution. Another important name mentioned was that of Dr. Carlos Marcílio (died in 2015), invited to structure the Stricto Sensu Graduate Program at Bahiana. Besides them, the contributions of Dr. Geraldo Leite and Dr. Agnaldo David de Souza (who died last August, victim of COVID-19) were also remembered. According to the dean of Bahiana, the best way to honor and thank the creators of the Stricto Sensu Graduate Program at Bahiana is to be inspired by the legacy they left behind, following some characteristics: "The restlessness about life, the courage to tread unfamiliar paths, the willpower, persistence, the ability to dream and turn dreams into reality. (...) The conviction that we shouldn't wait for someone to solve the problems we've identified in the world for us, but rather take them in our hands, find the solutions. The formation of a taste for art, literature, philosophy. The search for the beautiful and for the good, respect for science, for doing science. The dedication to taking care of people, especially those most in need who need us most. (...) The individual responsibility of each one of us in making the world a place best".
Present and future of PPgMSH
“The Master's and Doctoral graduate program in Medicine and Human Health is constantly evolving, always looking for improvements in the sense of promoting adaptation to the new economic, political and scientific reality of public health not only in the country, but also in the world. So, our program works a lot with applied research in clinical practice so that it can have a direct impact on people's lives and on scientific knowledge”, declares Dr. Ana Marice Ladeia. She explains that the program is interdisciplinary and multidisciplinary, receiving academics from different areas of health, and is based on Evidence-Based Medicine.
According to her, the program has been planned to evolve more and more towards offering internationalization and greater social inclusion. "From a scientific point of view, we have always sought to evolve through research with greater scientific integrity, greater transparency and a focus on evidence-based medicine", explains Dr. Ana Marice.
The program coordinator also points out that, for the next four years, a partnership is being signed with the Teaching Assistance Clinic of Bahiana (ADAB) for the creation of a center for clinical research, whose main theme will be tuberculosis. The center will also support the management of research projects related to the program. "Another important aspect is that the postgraduate program, currently, already has a line related to evidence-based medicine, metasciences, and intends to evolve more and more in this direction, anchored in the Evidence-Based Medicine Center of the Bahiana, which is coordinated by Professor Luis Cláudio Correia, who is also a professor at the Graduate Program in Medicine and Human Health", reports Ana Marice.
The highlight of the International Webinar schedule was the chat entitled "A Critical View of Evidence-Based Medicine", with the mediation of Prof. Dr. Luís Cláudio Correia, who also presented the lecture “Irrationalites os Medical Cognition”. The guest Dr. John Mandrola, member of the medical staff of the Baptist Hospital Health, in Louisville, Kentucky (USA), columnist and editor of Medscape's "This Week in Cardiology" podcast, he brought to the debate the theme “Scientific Bias in the World of Cardiology – A critical view of Evidence-Based-Medcine”.
The second guest, Dr. Robert Kaplan, adjunct professor at Stanford University (USA), where he is also research director of Clinical Excelent Research, presented the lecture "Evidence for Approval of New Drugs by the US FDA".
The event's audience included the participation of professionals and researchers from several Brazilian states and other countries, who had the opportunity to clarify doubts and also share experiences on the themes addressed in the webinar.